Market News Archives

Record Highs for Dow and S&P 500: Eli Lilly Shines, Oracle Sinks AI Sentiment This Week – December 12, 2025 -( $LLY $MCD $NOK $PL $PLTR $RIO $TSLA Rise!)

by Vista Partners LLC December 12, 2025 2365Views 0Likes

Wall Street limped into the weekend looking like a marathoner who realized the finish line had quietly moved 100 yards farther away: still standing, but with the AI high-fliers suddenly short of breath and old‑economy cyclicals enjoying a late‑season second wind. Indexes:…

From Pixels to Profits: Planet Labs Turns Satellite Imagery into a Down-to-Earth Cash Machine -( $PL $NFLX )

by Vista Partners LLC December 12, 2025 559Views 0Likes

Planet Labs (NYSE: PL) just delivered the kind of quarter that makes even jaded space investors sit up straighter, with revenue blasting past expectations and guidance pointing to a company finally acting like a real business instead of a science project in…

Eupraxia Pharmaceuticals: The Small‑Cap Biotech Quietly Seeking To Build a Billion‑Dollar Plus EoE Franchise -( $EPRX $IBB $XBI )

by Vista Partners LLC December 12, 2025 760Views 0Likes

Eupraxia Pharmaceuticals (NASDAQ: EPRX, $6.40, +1.59% today and +85.51% over the last year) is emerging as a standout small‑cap biotech, transforming a once‑niche GI indication and routine endoscopy visits into a compelling, scalable growth platform, underpinned by a mid‑teens price target from…

Dow and S&P 500 Hit New Highs While Tech Wobbles: Tariffs, Fed Cuts, and IPOs Shape December 11, 2025 Trading -( $EPRX $LMRI $MODD $NOK $OKLO $OPEN $PL $RIO $SOAR Rise!)

by Vista Partners LLC December 11, 2025 2286Views 0Likes

Wall Street ended Thursday with the Dow and S&P 500 looking like they’d just discovered compound interest, while the Nasdaq nursed an AI hangover and small caps quietly joined the advance. The Dow Jones Industrial Average surged about 1.3% to a fresh…

Modular Medical Bets on ~$3B Market for “Almost-Pumpers,” Taps Wall Street to Fuel Next-Gen Insulin Patch Pumps -( $MODD )

by Vista Partners LLC December 11, 2025 840Views 0Likes

In a season when most micro-cap CEOs are more focused on keeping the lights on than rewriting the diabetes playbook, Modular Medical (MODD) is trying to do both – and pass the hat on Wall Street at the same time. The San…

GE Vernova Doubles Dividend: How a New Energy Powerhouse Just Joined Wall Street’s Cash‑Return Elite -( $GEV $SPY )

by Vista Partners LLC December 11, 2025 719Views 0Likes

GE Vernova’s (NYSE: GEV) decision to double its quarterly dividend for early 2026 reads less like a routine board action and more like a coming‑of‑age announcement from Wall Street’s newest power broker in the energy transition trade. In a market where “capital…

Rate Cuts, Curves and Chips: How the Fed’s Quarter-Point Trim Reshaped Wednesday’s Tape – December 10, 2025 -( $AAPL $ABVX $AVGO $DV $EPRX $INTC $INTG $LLY $NOK $PLTR $RIO $TSLA $TSM Rise!)

by Vista Partners LLC December 10, 2025 2024Views 0Likes

Markets leaned into the Fed’s latest cut with the kind of cautious enthusiasm usually reserved for a long‑overdue bonus. Major indexes U.S. stocks spent Wednesday strutting rather than sprinting, as the S&P 500 rose about 0.7% to roughly 6,887, just shy of…

Inside GeoVax’s Big-League Scientific Upgrade: Global Experts Join the Fight Against Cancer and Deadly Viruses -( $GOVX $AZN $IBB $XBI )

by Vista Partners LLC December 10, 2025 671Views 0Likes

GeoVax’s (NASDAQ: GOVX) latest boardroom move reads like a biotech who’s-who casting call, with the Atlanta-based vaccine developer quietly assembling a scientific brain trust that looks less like a small-cap advisory board and more like a Davos side panel on immunology. A…

Magnets in Beijing, Gallium in the Outback: Inside the New Great Game for Critical Metals -( $MTWO $SOAR )

by Vista Partners LLC December 10, 2025 585Views 0Likes

In a week when markets were supposed to be focused on holiday retail and year-end dot plots, the real action was happening in places that do not show up on Black Friday traffic Chinese export control offices and a Western Australian gallium…

The Year of the Bispecific: Biotech’s Double-Edged Breakout -( $ARKG $IBB $XBI $RHBBY $AMGN $JNJ )

by Vista Partners LLC December 10, 2025 455Views 0Likes

If 2024 crowned weight-loss drugs the belle of the healthcare ball, 2025 belongs to the bispecific antibody. What began as a niche in immuno-oncology has evolved into biotech’s most competitive—and potentially lucrative—battleground, drawing fresh capital, dealmaking, and analyst optimism that borders on…

Market News

Your Guide To Staying Informed In The Markets